moxetumomab pasudotox

AstraZeneca grabs an FDA OK for its new leukemia drug, to be marketed as Lumoxiti
Endpoints
Thu, 09/13/18 - 11:22 pm
AstraZeneca
hairy cell leukemia
moxetumomab pasudotox
AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials
Bloomberg
Thu, 05/16/13 - 10:33 am
AstraZeneca
moxetumomab pasudotox
hairy cell leukemia
olaparib
ovarian cancer
selumetinib
non-small cell lung cancer